Average Co-Inventor Count = 5.76
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada & Co. (3 from 80 patents)
2. Other (1 from 832,912 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5 patents:
1. 8552193 - Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide
2. 7560559 - Polymorphic form of montelukast sodium
3. 6740666 - Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
4. 6232472 - Synthesis of 4-[(5-substituted phenyl)-3-substituted-1H-pyrazol-1-yl]benzenesulfonamide
5. 6150534 - Synthesis of 4-[5-substituted or unsubstituted